Strides Pharma Science Limited (NSE:STAR)

Strides Pharma Science Revenue

Strides Pharma Science had revenue of 14.30B INR in the quarter ending September 30, 2026, with 17.11% growth. This brings the company's total for the last twelve months to 52.13B, up 11.28% year-over-year. In the fiscal year ending March 31, 2026, Strides Pharma Science had annual revenue of 48.59B with 6.43% growth. That makes Strides Pharma Science the 10,664th largest company in the world by revenue and 470th in India.

• Revenue (ttm): 52.13B
• Revenue Growth: +11.28%
• P/S Ratio: 1.79
• Revenue / Employee: 14.75M
• Employees: 3,535
• Market Cap: 93.28B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• North America 24.89B 51.2%
• Europe 10.27B 21.1%
• Africa 5.52B 11.4%
• Australia 5.08B 10.5%
• Unallocated 2.31B 4.7%
• Others 176.93M 0.4%
• India 173.72M 0.4%
• Asia (Excluding India) 173.57M 0.4%

Fiscal year ended Mar 31, 2026 See the full Strides Pharma Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	48.59B	2.93B	6.43%
Mar 31, 2025	45.65B	6.75B	17.36%
Mar 31, 2024	38.90B	2.02B	5.47%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error